Have a personal or library account? Click to login
The Evaluation of the Effects of N-Acetylcysteine on Cisplatin-Induced Alterations in Exploratory Activity in Elevated Plus Maze Test in Rats Cover

The Evaluation of the Effects of N-Acetylcysteine on Cisplatin-Induced Alterations in Exploratory Activity in Elevated Plus Maze Test in Rats

By: Milica Pantic and  Milos Minic  
Open Access
|May 2019

References

  1. 1. Bednarski PJ, Korpis K, Westendorf AF, Perfahl S, Grünert R. Effects of light-activated diazido-PtIV complexes on cancer cells in vitro. Philos Trans A Math Phys Eng Sci. 2013;17:371.
  2. 2. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994-1007.10.1038/sj.ki.500278618272962
  3. 3. Waseem M, Bhardwaj M, Tabassum H, Raisuddin S, Parvez S. Cisplatin hepatotoxicity mediated by mitochondrial stress. Drug Chem Toxicol. 2015;38(4):452-9.10.3109/01480545.2014.99243725678195
  4. 4. Oun R, Rowan E. Cisplatin induced arrhythmia; electrolyte imbalance or disturbance of the SA node? Eur J Pharmacol. 2017;811:125-8.
  5. 5. Karale S, Kamath JV. Effect of daidzein on cisplatininduced hematotoxicity and hepatotoxicity in experimental rats. Indian J Pharmacol. 2017;49(1):49-54.10.4103/0253-7613.201022
  6. 6. Navari RM, Quin R, Ruddy KJ, Liu H, Powel SF, Bajaj M, Dietrich L, Biggs D, Lafky JM, Loprinzi CL. Olazapine for the prevention chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;375(2):134-42.10.1056/NEJMoa1515725534445027410922
  7. 7. Kanat O, Ertas H, Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol. 2017;8(4):329-35.10.5306/wjco.v8.i4.329555487628848699
  8. 8. Krarup-Hansen A, Fugleholm K, Helweg-Larsen S, Hauge EN, Schmalbruch H, Trojaborg W, Krarup C. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain. 1993;116 (5):1017-41.10.1093/brain/116.5.10178221046
  9. 9. Matsuoka A, Mitsuma A, Maeda O, Kajiyama H, Kiyoi H, Kodera Y, Nagino M, Goto H, Ando Y. Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device. Cancer Sci. 2016;107(10):1453-7.10.1111/cas.13010508465527412083
  10. 10. Golchin L, Shabani M, Harandi S, Razavinasab M. Pistachio supplementation attenuates motor and cognition impairments induced by cisplatin or vincristine in rats. Adv Biomed Res. 2015;4:92.10.4103/2277-9175.156656443448726015918
  11. 11. Lomeli N, Di K, Czerniawski J, Guzowski JF, Bota DA. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med. 2017;102:274-86.10.1016/j.freeradbiomed.2016.11.046530845027908784
  12. 12. Abdelkader NF, Saad MA, Abdelsalam RM. Neuroprotective effect of nebivolol against cisplatin-associated depressive-like behavior in rats. J Neurochem. 2017;141(3):449-60.10.1111/jnc.1397828178754
  13. 13. Lee KH, Rhee KH. Anti-nociceptive effect of Agrimonia eupatoria exstract on a cisplatin-induced neurophatic model. Afr J Tradit Complement Altern Med. 2016;13(5):139-44.10.21010/ajtcam.v13i5.18
  14. 14. Santos NA, Catão CS, Martins NM, Curti C, Bianchi ML, Santos AC. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol. 2007;81(7):495-504.10.1007/s00204-006-0173-217216432
  15. 15. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334(2):115-24.10.1097/MAJ.0b013e31812dfe1e
  16. 16. Nishikawa M, Nagatomi H, Nishijima M, Ohira G, Chang BJ, Sato E, Inoue M. Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer- bearing mice. Cancer Lett. 2001;171(2):133-8.10.1016/S0304-3835(01)00591-2
  17. 17. Zheng ZG, Xu H, Suo SS, Xu XL, Ni MW, Gu LH, Chen W, Wang LY, Zhao Y, Tian B, Hua YJ. The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer. Sci Rep.2016;6:26093.10.1038/srep26093487213327193186
  18. 18. Guindon J, Deng L, Fan B, Wager-Miller J, Hohmann AG. Optimization of a cisplatin model of chemotherapy- induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status. Mol Pain. 2014;10:56.10.1186/1744-8069-10-56424777025189223
  19. 19. Villani V, Zucchella C, Cristalli G, Galiè E, Bianco F, Giannarelli D, Carpano S, Spriano G, Pace A. Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial. Head Neck. 2016;38(1):2118-21.10.1002/hed.2439626849799
  20. 20. Doğan S, Yazici H, Yalçinkaya E, Erdoğdu HI, Tokgöz SA, Sarici F, Namuslu M, Sarikaya Y. Protective Effect of Selenium Against Cisplatin-Induced Ototoxicity in an Experiemental Model. J Craniofac Surg. 2016;27(7):610-4.10.1097/SCS.000000000000294227741210
  21. 21. Ali DA, Abdeen AM, Ismail MF, Mostafa MA. Histological, ultrastructural and immunohistochemical studies on the protective effect of ginger extract against cisplatin-induced nephrotoxicity in male rats. Toxicol Ind Health. 2015;31(10):869-80.10.1177/074823371348319823552260
  22. 22. Yüce A, Ateşşahin A, Ceribaşi AO, Aksakal M. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin Pharmacol Toxicol. 2007;101(5):345-9.10.1111/j.1742-7843.2007.00129.x17910619
  23. 23. Zhu J, Carozzi VA, Reed N, Mi R, Marmiroli P, Cavaletti G, Hoke A. Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity. Sci Rep. 2016;6:28861.10.1038/srep28861492409127350330
  24. 24. Shokoohinia Y, Khajouei S, Ahmadi F, Ghiasvand N, Hosseinzadeh L. Protective effect of bioactive compounds from Echinophora cinerea against cisplatininduced oxidative stress and apoptosis in the PC12 cell line. Iran J Basic Med Sci. 2017;20(4):438-45.
  25. 25. Ribeiro N, Thuaud F, Bernard Y, Gaiddon C, Cresteil T, Hild A, Hirsch EC, Michel PP, Nebigil CG, Désaubry L. Flavaglines as potent anticancer and cytoprotective agents. J Med Chem. 2012;55(22):10064-73.10.1021/jm301201z23072299
  26. 26. Wiechno P, Demkow T, Kubiak K, Sadowska M, Kamińska J. The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era. Eur Urol. 2007;52(5):1448-54.10.1016/j.eururo.2007.05.012
  27. 27. Eberhard J, Ståhl O, Cohn-Cedermark G, Cavallin- Ståhl E, Giwercman Y, Rastkhani H, Rylander L, Eberhard- Gran M, Kvist U, Giwercman A. Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality. J Affect Disord. 2010;122(3):260-6.10.1016/j.jad.2009.06.035
  28. 28. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-67.10.1016/0165-0270(85)90031-7
  29. 29. Selakovic D, Joksimovic J, Obradovic D, Milovanovic D, Djuric M, Rosic G. The adverse effects of exercise and supraphysiological dose of testosterone-enanthate (TE) on exploratory activity in elevated plus maze (EPM) test - indications for using total exploratory activity (TEA) as a new parameter for ex. Neuro Endocrinol Lett. 2016;37(5):383-8.
  30. 30. Kawanishi S, Yamamoto K. Mechanism of site-specific DNA damage induced by methylhydralazines in the presence of cooper (II) or manganese (III). Biochemistry. 1991;30(12):3069-75.10.1021/bi00226a0131848785
  31. 31. Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol. 2009;47(6):1176-83.10.1016/j.fct.2009.02.00719425235
  32. 32. Townsend DM, Tew KD, He L, King JB, Hanigan MH. Role of glutathione S-transferase Pi in cisplatin- induced nephrotoxicity. Biomed Pharmacother. 2009;63(2):79-85.1881977010.1016/j.biopha.2008.08.004266769918819770
  33. 33. Rosic G, Selakovic D, Joksimovic J, Srejovic I, Zivkovic V, Tatalovic N, Orescanin-Dusic Z, Mitrovic S, Ilic M, Jakovljevic V. The effects of N-acetylcysteine on cisplatin- induced changes of cardiodynamic parameters within coronary autoregulation range in isolated rat hearts. Toxicol Lett. 2016;242:34-46.10.1016/j.toxlet.2015.11.02826656795
  34. 34. Costa AA, Morato S, Roque AC, Tinos R. A computational model for exploratory activity of rats with different anxiety levels in elevated plus-maze. J Neurosci Methods. 2014;236:44-50.10.1016/j.jneumeth.2014.08.00625128721
  35. 35. Mu L, Wang J, Cao B, Jelfs B, Chan RH, Xu X, Hasan M, Zhang X, Li Y. Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex. Mol Brain. 2015;8:32.10.1186/s13041-015-0125-y449072126001812
  36. 36. Wang W, Li D, Ding X, Zhao Q, Chen J, Tian K, Qiu Y, Lu L. N-Acetylcysteine protects inner ear hair cells and spiral ganglion neurons from manganese exposure by regulating ROS levels. Toxicol Lett. 2017; 279:77-86.10.1016/j.toxlet.2017.07.90328778520
  37. 37. Wang J, Zhu H, Liu X, Liu Z. N-acetylcysteine protects against cadmium-induced oxidative stress in rat hepatocytes. J Vet Sci. 2014;15(4):485-93.10.4142/jvs.2014.15.4.485426959025234327
  38. 38. Ortiz MS, Forti MK, Suarez Martinez BE, Munoz GL, Husain K, Muniz HW. Effects of antioxidant N-acetylcysteine against paraquat-induced oxidative stress in vital tissues mice. Int J Sci Basic Appl Res. 2016;26(1):26-46.
  39. 39. Shabani M, Nazeri M, Parsania S, Razavinasab M, Zangiabadi N, Esmaeilpour K, Abareghi F. Walnut consumption protects rats against cisplatin-induced neurotoxicity. Neurotoxicology. 2012;33(5):1314-21.10.1016/j.neuro.2012.08.00422935099
DOI: https://doi.org/10.1515/sjecr-2017-0053 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 65 - 72
Submitted on: Oct 13, 2017
|
Accepted on: Oct 16, 2017
|
Published on: May 16, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Milica Pantic, Milos Minic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.